Detalhe da pesquisa
1.
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial.
Lancet Oncol
; 20(1): 31-42, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30518502
2.
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma.
Blood Adv
; 4(19): 4898-4911, 2020 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33035333
3.
Safety, pharmacokinetics, and efficacy of AMG 706, an oral multikinase inhibitor, in patients with advanced solid tumors.
J Clin Oncol
; 25(17): 2369-76, 2007 Jun 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-17557949